| DY2 Stock | | | EUR 18.16 0.29 1.57% |
Director
Dr. Michael C. Alfano, Ph.D., is an Independent Director of the Company. Dr. Alfano is Executive Vice President Emeritus, and Professor and Dean Emeritus at New York University . Dr. Alfano served as Dean of the College of Dentistry from 1998 to 2006 and as Executive VicePresident of NYU from 2006 to 2013. Beginning in 1982 until 1998 he held a number of positions with Block Drug Company, including Senior Vice President for Research Technology and President of Block Professional Dental Products Company. He served on the Board of Directors of Block Drug Company, Inc. from 1988 to 1998. Dr. Alfano has served as a member of, or consultant to, various public health organizations, including the National Institutes of Health, the Editorial Board of the American Journal of Dentistry, the Consumer Healthcare Product Association and as the industry representative to the NonPrescription Drugs Advisory Committee of the FDA from 2001 to 2005. He was a founding director of the Friends of the National Institute for Dental and Craniofacial Research, and he is a founding director of the notforprofit Santa Fe Group. He was also a Trustee of the New York State Dental Foundation until 2006. From 20102015 he served as a director of the notforprofit Delta Dental of New York Insurance Company. He also served as a Director of the YMCA of Greater New York, the largest YMCA system in the country, from 2010 to 2014. He has received numerous honors, research grants and awards, and currently serves as President of the Santa Fe Group. since 2001.
| Age | 71 |
| Tenure | 23 years |
| Phone | 844-848-0137 |
| Web | https://www.dentsplysirona.com |
Dentsply Sirona Management Efficiency
The company has return on total asset
(ROA) of
0.0345 % which means that it generated a profit of $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.2157) %, meaning that it generated substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities.
Dentsply Sirona has accumulated 1.83
B in total debt with debt to equity ratio
(D/E) of 0.48, which is about average as compared to similar companies. Dentsply Sirona has a current ratio of 1.37, which is within standard range for the sector. Debt can assist Dentsply Sirona until it has trouble settling it off, either with new capital or with free cash flow. So, Dentsply Sirona's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dentsply Sirona sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dentsply to invest in growth at high rates of return. When we think about Dentsply Sirona's use of debt, we should always consider it together with cash and equity.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina. DENTSPLY SIRONA operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15000 people. Dentsply Sirona (DY2) is traded on Frankfurt Exchange in Germany and employs 51 people.
Management Performance
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Wagner, Chief Officer | |
| Janet Vergis, Independent Director | |
| Cheree Johnson, Chief VP | |
| Lisa Yankie, Senior Vice President Chief Human Resources Officer and Communications | |
| Francis Lunger, Independent Director | |
| Jorge Gomez, Chief Financial Officer, Executive Vice President | |
| Chidam Chidambaram, Senior Vice President Chief Digital Officer | |
| Andrew Robinson, VP Officer | |
| Ranjit Chadha, Chief Accounting Officer, Principal Accounting Officer | |
| Andrea Daley, VP Relations | |
| Harry Kraemer, Independent Director | |
| Betsy Holden, Independent Director | |
| Leslie Varon, Independent Director | |
| Eric Brandt, Non-Executive Independent Chairman of the Board | |
| Gregory Lucier, Independent Director | |
| Donald Casey, Chief Executive Officer, Director | |
| William Newell, Senior Vice President Chief Segment Officer | |
| Andreas Frank, Ex Group | |
| Willie Deese, Independent Director | |
| Daniel Key, Senior Vice President Chief Supply Chain Officer | |
| Simon Campion, Pres CEO | |
| Erania Brackett, VP Officer | |
| Walter Petersohn, Senior Vice President Chief Commercial Officer | |
| Matthew Coggin, Senior Vice President Business Development and Strategy Officer | |
| Keith Ebling, Executive Vice President General Counsel, Secretary | |
| Michael Alfano, Independent Director | |
| Clyde Hosein, Director | |
| Cord Staehler, Senior Vice President, Chief Technology Officer | |
| Arthur Kowaloff, Independent Director | |
| Glenn Coleman, Ex CFO | |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Dentsply Stock
When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock: Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more detail on how to invest in Dentsply Stock please use our
How to Invest in Dentsply Sirona guide.
You can also try the
Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.